+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vascular Graft Market by Product, Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, and Biosynthetic) and End User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 220 Pages
  • February 2022
  • Region: Global
  • Allied Market Research
  • ID: 5578143
UP TO OFF until Oct 24th 2024
The global vascular graft market was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030..



A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels. Vascular grafts are used for the treatment of vascular diseases such as pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. The incidence of vascular diseases has increased significantly over the last few years. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019. Vascular diseases may be caused due to high blood pressure, cholesterol deposition, injury, genetic, and infections.

Vascular grafts are mainly made of polyester, polytetrafluoroethylene (PTFE), and polyurethane material. However, biosynthetic vascular grafts are also available in market. The vascular grafts are classified as hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular stent grafting, or endovascular aneurysm repair (EVAR), is a newer form of treatment for abdominal aortic aneurysm that is less invasive than open surgery. Endovascular stent graft is used to reinforce the wall of the aorta and to help keep the damaged area from rupturing.

The increase in the prevalence of vascular diseases globally drives the growth of vascular grafts market. For instance, according to report by American Heart Association, in 2019, 197.2 million people lived with ischemic heart disease (IHD). In addition, the increase in diabetes and hypertension propels the growth of vascular disease devices market. According to World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years had hypertension. The older age people are more susceptible to vascular disease and the rise in the geriatric population further contributes in the growth of the vascular grafts market.

In addition, increase in the sedentary lifestyle and unhealthy food eating habits contribute in the growth of the vascular grafts market. However, the high cost of vascular surgery and product failures are expected to limit the growth of the market.

The vascular grafts market is segmented on the basis of product, raw material, end user, and regions. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). By raw material, it is categorized in to polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. By end user, it is divided into hospitals and ambulatory surgical centers (ASCs). By Region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation and W. L. Gore & Associates, Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global vascular grafts market size along with the current trends and future estimations to elucidate the imminent investment pockets
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
  • A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global vascular grafts market growth

KEY MARKET SEGMENTS


By Product

  • Hemodialysis Access Graft
  • Endovascular Aneurysm Repair Stent Grafts
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
  • Peripheral Vascular Graft

By Raw Material

  • Polyester
  • Polytetrafluoroethylene (PTFE)
  • Polyurethane
  • Biosynthetic

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • B Braun Melsungen AG
  • Becton, Dickinson And Company
  • Cook Medical, Inc
  • Cordis
  • Endologix Inc
  • Getinge Group
  • LeMaitre Vascular Inc
  • Medtronic plc
  • Terumo Medical Corporation
  • W. L Gore & Associates, Inc

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
Chapter 4: Vascular Graft Market, by Products
4.1. Market Overview
4.1.1Market Size and Forecast, by Products
4.2. Hemodialysis Access Graft
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Endovascular Aneurysm Repair Stent Grafts
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
4.3.4. Abdominal Aortic Aneurysm (Aaa)
4.3.4.1. Market Size and Forecast
4.3.5. Thoracic Aortic Aneurysm (Taa)
4.3.5.1. Market Size and Forecast
4.4. Peripheral Vascular Graft
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Share Analysis, by Country
Chapter 5: Vascular Graft Market, by Raw Material
5.1. Market Overview
5.1.1Market Size and Forecast, by Raw Material
5.2. Polyester
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, by Region
5.2.3. Market Share Analysis, by Country
5.3. Polytetrafluoroethylene (Ptfe)
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, by Region
5.3.3. Market Share Analysis, by Country
5.4. Polyurethane
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, by Region
5.4.3. Market Share Analysis, by Country
5.5. Biosynthetic
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, by Region
5.5.3. Market Share Analysis, by Country
Chapter 6: Vascular Graft Market, by End-user
6.1. Market Overview
6.1.1Market Size and Forecast, by End-user
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, by Region
6.2.3. Market Share Analysis, by Country
6.3. Ambulatory Surgical Centers (Ascs)
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, by Region
6.3.3. Market Share Analysis, by Country
Chapter 7: Vascular Graft Market, by Region
7.1. Market Overview
7.1.1Market Size and Forecast, by Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, by Products
7.2.3. Market Size and Forecast, by Raw Material
7.2.4. Market Size and Forecast, by End-user
7.2.5. Market Size and Forecast, by Country
7.2.6. United States Vascular Graft Market
7.2.6.1. Market Size and Forecast, by Products
7.2.6.2. Market Size and Forecast, by Raw Material
7.2.6.3. Market Size and Forecast, by End-user
7.2.7. Canada Vascular Graft Market
7.2.7.1. Market Size and Forecast, by Products
7.2.7.2. Market Size and Forecast, by Raw Material
7.2.7.3. Market Size and Forecast, by End-user
7.2.8. Mexico Vascular Graft Market
7.2.8.1. Market Size and Forecast, by Products
7.2.8.2. Market Size and Forecast, by Raw Material
7.2.8.3. Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, by Products
7.3.3. Market Size and Forecast, by Raw Material
7.3.4. Market Size and Forecast, by End-user
7.3.5. Market Size and Forecast, by Country
7.3.6. France Vascular Graft Market
7.3.6.1. Market Size and Forecast, by Products
7.3.6.2. Market Size and Forecast, by Raw Material
7.3.6.3. Market Size and Forecast, by End-user
7.3.7. Germany Vascular Graft Market
7.3.7.1. Market Size and Forecast, by Products
7.3.7.2. Market Size and Forecast, by Raw Material
7.3.7.3. Market Size and Forecast, by End-user
7.3.8. Italy Vascular Graft Market
7.3.8.1. Market Size and Forecast, by Products
7.3.8.2. Market Size and Forecast, by Raw Material
7.3.8.3. Market Size and Forecast, by End-user
7.3.9. Spain Vascular Graft Market
7.3.9.1. Market Size and Forecast, by Products
7.3.9.2. Market Size and Forecast, by Raw Material
7.3.9.3. Market Size and Forecast, by End-user
7.3.10. U. K Vascular Graft Market
7.3.10.1. Market Size and Forecast, by Products
7.3.10.2. Market Size and Forecast, by Raw Material
7.3.10.3. Market Size and Forecast, by End-user
7.3.11. Rest of Europe Vascular Graft Market
7.3.11.1. Market Size and Forecast, by Products
7.3.11.2. Market Size and Forecast, by Raw Material
7.3.11.3. Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, by Products
7.4.3. Market Size and Forecast, by Raw Material
7.4.4. Market Size and Forecast, by End-user
7.4.5. Market Size and Forecast, by Country
7.4.6. China Vascular Graft Market
7.4.6.1. Market Size and Forecast, by Products
7.4.6.2. Market Size and Forecast, by Raw Material
7.4.6.3. Market Size and Forecast, by End-user
7.4.7. Japan Vascular Graft Market
7.4.7.1. Market Size and Forecast, by Products
7.4.7.2. Market Size and Forecast, by Raw Material
7.4.7.3. Market Size and Forecast, by End-user
7.4.8. India Vascular Graft Market
7.4.8.1. Market Size and Forecast, by Products
7.4.8.2. Market Size and Forecast, by Raw Material
7.4.8.3. Market Size and Forecast, by End-user
7.4.9. South Korea Vascular Graft Market
7.4.9.1. Market Size and Forecast, by Products
7.4.9.2. Market Size and Forecast, by Raw Material
7.4.9.3. Market Size and Forecast, by End-user
7.4.10. Australia Vascular Graft Market
7.4.10.1. Market Size and Forecast, by Products
7.4.10.2. Market Size and Forecast, by Raw Material
7.4.10.3. Market Size and Forecast, by End-user
7.4.11. Rest of Asia-Pacific Vascular Graft Market
7.4.11.1. Market Size and Forecast, by Products
7.4.11.2. Market Size and Forecast, by Raw Material
7.4.11.3. Market Size and Forecast, by End-user
7.5. Lamea
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, by Products
7.5.3. Market Size and Forecast, by Raw Material
7.5.4. Market Size and Forecast, by End-user
7.5.5. Market Size and Forecast, by Country
7.5.6. Brazil Vascular Graft Market
7.5.6.1. Market Size and Forecast, by Products
7.5.6.2. Market Size and Forecast, by Raw Material
7.5.6.3. Market Size and Forecast, by End-user
7.5.7. South Africa, Vascular Graft Market
7.5.7.1. Market Size and Forecast, by Products
7.5.7.2. Market Size and Forecast, by Raw Material
7.5.7.3. Market Size and Forecast, by End-user
7.5.8. Saudi Arabia Vascular Graft Market
7.5.8.1. Market Size and Forecast, by Products
7.5.8.2. Market Size and Forecast, by Raw Material
7.5.8.3. Market Size and Forecast, by End-user
7.5.9. Rest of LAMEA Vascular Graft Market
7.5.9.1. Market Size and Forecast, by Products
7.5.9.2. Market Size and Forecast, by Raw Material
7.5.9.3. Market Size and Forecast, by End-user
Chapter 8: Company Profiles
8.1. B. Braun Melsungen AG
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Becton, Dickinson and Company
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Cook Medical Inc
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Cordis
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Endologix Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Getinge Group
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Lemaitre Vascular Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Medtronic, Inc.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Terumo Medical Corporation
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. W. L. Gore and Associates, Inc.
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
List of Tables
Table 1. Global Vascular Graft Market, by Products, 2020-2030 ($Million)
Table 2. Global Vascular Graft Market for Hemodialysis Access Graft, by Region, 2020-2030 ($Million)
Table 3. Global Vascular Graft Market for Endovascular Aneurysm Repair Stent Grafts, by Region, 2020-2030 ($Million)
Table 4. Global Vascular Graft Market for Peripheral Vascular Graft, by Region, 2020-2030 ($Million)
Table 5. Global Vascular Graft Market, by Raw Material, 2020-2030 ($Million)
Table 6. Global Vascular Graft Market for Polyester, by Region, 2020-2030 ($Million)
Table 7. Global Vascular Graft Market for Polytetrafluoroethylene (Ptfe), by Region, 2020-2030 ($Million)
Table 8. Global Vascular Graft Market for Polyurethane, by Region, 2020-2030 ($Million)
Table 9. Global Vascular Graft Market for Biosynthetic, by Region, 2020-2030 ($Million)
Table 10. Global Vascular Graft Market, by End-user, 2020-2030 ($Million)
Table 11. Global Vascular Graft Market for Hospitals, by Region, 2020-2030 ($Million)
Table 12. Global Vascular Graft Market for Ambulatory Surgical Centers (Ascs), by Region, 2020-2030 ($Million)
Table 13. Global Vascular Graft Market, by Region, 2020-2030 ($Million)
Table 14. North America Vascular Graft, by Products, 2020-2030 ($Million)
Table 15. North America Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 16. North America Vascular Graft, by End-user, 2020-2030 ($Million)
Table 17. United States Vascular Graft, by Products, 2020-2030 ($Million)
Table 18. United States Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 19. United States Vascular Graft, by End-user, 2020-2030 ($Million)
Table 20. Canada Vascular Graft, by Products, 2020-2030 ($Million)
Table 21. Canada Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 22. Canada Vascular Graft, by End-user, 2020-2030 ($Million)
Table 23. Mexico Vascular Graft, by Products, 2020-2030 ($Million)
Table 24. Mexico Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 25. Mexico Vascular Graft, by End-user, 2020-2030 ($Million)
Table 26. Europe Vascular Graft, by Products, 2020-2030 ($Million)
Table 27. Europe Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 28. Europe Vascular Graft, by End-user, 2020-2030 ($Million)
Table 29. France Vascular Graft, by Products, 2020-2030 ($Million)
Table 30. France Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 31. France Vascular Graft, by End-user, 2020-2030 ($Million)
Table 32. Germany Vascular Graft, by Products, 2020-2030 ($Million)
Table 33. Germany Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 34. Germany Vascular Graft, by End-user, 2020-2030 ($Million)
Table 35. Italy Vascular Graft, by Products, 2020-2030 ($Million)
Table 36. Italy Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 37. Italy Vascular Graft, by End-user, 2020-2030 ($Million)
Table 38. Spain Vascular Graft, by Products, 2020-2030 ($Million)
Table 39. Spain Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 40. Spain Vascular Graft, by End-user, 2020-2030 ($Million)
Table 41. United Kingdom Vascular Graft, by Products, 2020-2030 ($Million)
Table 42. United Kingdom Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 43. United Kingdom Vascular Graft, by End-user, 2020-2030 ($Million)
Table 44. Rest of Europe Vascular Graft, by Products, 2020-2030 ($Million)
Table 45. Rest of Europe Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 46. Rest of Europe Vascular Graft, by End-user, 2020-2030 ($Million)
Table 47. Asia-Pacific Vascular Graft, by Products, 2020-2030 ($Million)
Table 48. Asia-Pacific Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 49. Asia-Pacific Vascular Graft, by End-user, 2020-2030 ($Million)
Table 50. China Vascular Graft, by Products, 2020-2030 ($Million)
Table 51. China Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 52. China Vascular Graft, by End-user, 2020-2030 ($Million)
Table 53. Japan Vascular Graft, by Products, 2020-2030 ($Million)
Table 54. Japan Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 55. Japan Vascular Graft, by End-user, 2020-2030 ($Million)
Table 56. India Vascular Graft, by Products, 2020-2030 ($Million)
Table 57. India Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 58. India Vascular Graft, by End-user, 2020-2030 ($Million)
Table 59. South Korea Vascular Graft, by Products, 2020-2030 ($Million)
Table 60. South Korea Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 61. South Korea Vascular Graft, by End-user, 2020-2030 ($Million)
Table 62. Australia Vascular Graft, by Products, 2020-2030 ($Million)
Table 63. Australia Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 64. Australia Vascular Graft, by End-user, 2020-2030 ($Million)
Table 65. Rest of Asia-Pacific Vascular Graft, by Products, 2020-2030 ($Million)
Table 66. Rest of Asia-Pacific Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 67. Rest of Asia-Pacific Vascular Graft, by End-user, 2020-2030 ($Million)
Table 68. Lamea Vascular Graft, by Products, 2020-2030 ($Million)
Table 69. Lamea Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 70. Lamea Vascular Graft, by End-user, 2020-2030 ($Million)
Table 71. Brazil Vascular Graft, by Products, 2020-2030 ($Million)
Table 72. Brazil Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 73. Brazil Vascular Graft, by End-user, 2020-2030 ($Million)
Table 74. South Africa, Vascular Graft, by Products, 2020-2030 ($Million)
Table 75. South Africa, Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 76. South Africa, Vascular Graft, by End-user, 2020-2030 ($Million)
Table 77. Saudi Arabia Vascular Graft, by Products, 2020-2030 ($Million)
Table 78. Saudi Arabia Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 79. Saudi Arabia Vascular Graft, by End-user, 2020-2030 ($Million)
Table 80. Rest of LAMEA Vascular Graft, by Products, 2020-2030 ($Million)
Table 81. Rest of LAMEA Vascular Graft, by Raw Material, 2020-2030 ($Million)
Table 82. Rest of LAMEA Vascular Graft, by End-user, 2020-2030 ($Million)
Table 83. B. Braun Melsungen Ag: Key Executives
Table 84. B. Braun Melsungen Ag: Company Snapshot
Table 85. B. Braun Melsungen Ag: Operating Segments
Table 86. B. Braun Melsungen Ag: Product Portfolio
Table 87. B. Braun Melsungen Ag: Key Strategic Moves and Developments
Table 88. Becton, Dickinson and Company: Key Executives
Table 89. Becton, Dickinson and Company: Company Snapshot
Table 90. Becton, Dickinson and Company: Operating Segments
Table 91. Becton, Dickinson and Company: Product Portfolio
Table 92. Becton, Dickinson and Company: Key Strategic Moves and Developments
Table 93. Cook Medical Inc: Key Executives
Table 94. Cook Medical Inc: Company Snapshot
Table 95. Cook Medical Inc: Operating Segments
Table 96. Cook Medical Inc: Product Portfolio
Table 97. Cook Medical Inc: Key Strategic Moves and Developments
Table 98. Cordis: Key Executives
Table 99. Cordis: Company Snapshot
Table 100. Cordis: Operating Segments
Table 101. Cordis: Product Portfolio
Table 102. Cordis: Key Strategic Moves and Developments
Table 103. Endologix Inc. : Key Executives
Table 104. Endologix Inc. : Company Snapshot
Table 105. Endologix Inc. : Operating Segments
Table 106. Endologix Inc. : Product Portfolio
Table 107. Endologix Inc. : Key Strategic Moves and Developments
Table 108. Getinge Group: Key Executives
Table 109. Getinge Group: Company Snapshot
Table 110. Getinge Group: Operating Segments
Table 111. Getinge Group: Product Portfolio
Table 112. Getinge Group: Key Strategic Moves and Developments
Table 113. Lemaitre Vascular Inc. : Key Executives
Table 114. Lemaitre Vascular Inc. : Company Snapshot
Table 115. Lemaitre Vascular Inc. : Operating Segments
Table 116. Lemaitre Vascular Inc. : Product Portfolio
Table 117. Lemaitre Vascular Inc. : Key Strategic Moves and Developments
Table 118. Medtronic, Inc. : Key Executives
Table 119. Medtronic, Inc. : Company Snapshot
Table 120. Medtronic, Inc. : Operating Segments
Table 121. Medtronic, Inc. : Product Portfolio
Table 122. Medtronic, Inc. : Key Strategic Moves and Developments
Table 123. Terumo Medical Corporation: Key Executives
Table 124. Terumo Medical Corporation: Company Snapshot
Table 125. Terumo Medical Corporation: Operating Segments
Table 126. Terumo Medical Corporation: Product Portfolio
Table 127. Terumo Medical Corporation: Key Strategic Moves and Developments
Table 128. W. L. Gore and Associates, Inc. : Key Executives
Table 129. W. L. Gore and Associates, Inc. : Company Snapshot
Table 130. W. L. Gore and Associates, Inc. : Operating Segments
Table 131. W. L. Gore and Associates, Inc. : Product Portfolio
Table 132. W. L. Gore and Associates, Inc. : Key Strategic Moves and Developments
List of Figures
Figure 1. Global Vascular Graft Market Segmentation
Figure 2. Global Vascular Graft Market
Figure 3. Segmentation Vascular Graft Market
Figure 4. Top Investment Pocket in Vascular Graft Market
Figure 5. Top Winning Strategies, 2019-2021*
Figure 6. Top Winning Strategies, by Development, 2019-2021(%)
Figure 7. Top Winning Strategies, by Company, 2019-2021*
Figure 8. Moderate Bargaining Power of Buyers
Figure 9. Moderate Bargaining Power of Suppliers
Figure 10. Moderate Threat of New Entrants
Figure 11. Low Threat of Substitution
Figure 12. High Competitive Rivalry
Figure 13. Top Player Positioning, 2020
Figure 14. Market Share Analysis, 2020
Figure 15. Restraints and Drivers: Vascular Graft Market
Figure 16. Vascular Graft Market Segmentation, by Products
Figure 17. Vascular Graft Market for Hemodialysis Access Graft, by Country, 2020-2030 ($ Million)
Figure 18. Vascular Graft Market for Endovascular Aneurysm Repair Stent Grafts, by Country, 2020-2030 ($ Million)
Figure 19. Vascular Graft Market for Peripheral Vascular Graft, by Country, 2020-2030 ($ Million)
Figure 20. Vascular Graft Market Segmentation, by Raw Material
Figure 21. Vascular Graft Market for Polyester, by Country, 2020-2030 ($ Million)
Figure 22. Vascular Graft Market for Polytetrafluoroethylene (Ptfe), by Country, 2020-2030 ($ Million)
Figure 23. Vascular Graft Market for Polyurethane, by Country, 2020-2030 ($ Million)
Figure 24. Vascular Graft Market for Biosynthetic, by Country, 2020-2030 ($ Million)
Figure 25. Vascular Graft Market Segmentation, by End-user
Figure 26. Vascular Graft Market for Hospitals, by Country, 2020-2030 ($ Million)
Figure 27. Vascular Graft Market for Ambulatory Surgical Centers (Ascs), by Country, 2020-2030 ($ Million)
Figure 28. B. Braun Melsungen Ag: Net Sales, 2018-2020 ($ Million)
Figure 29. B. Braun Melsungen Ag: Revenue Share, by Segment, 2020 (%)
Figure 30. B. Braun Melsungen Ag: Revenue Share, by Region, 2020 (%)
Figure 31. Becton, Dickinson and Company: Net Sales, 2018-2020 ($ Million)
Figure 32. Becton, Dickinson and Company: Revenue Share, by Segment, 2020 (%)
Figure 33. Becton, Dickinson and Company: Revenue Share, by Region, 2020 (%)
Figure 34. Cook Medical Inc: Net Sales, 2018-2020 ($ Million)
Figure 35. Cook Medical Inc: Revenue Share, by Segment, 2020 (%)
Figure 36. Cook Medical Inc: Revenue Share, by Region, 2020 (%)
Figure 37. Cordis: Net Sales, 2018-2020 ($ Million)
Figure 38. Cordis: Revenue Share, by Segment, 2020 (%)
Figure 39. Cordis: Revenue Share, by Region, 2020 (%)
Figure 40. Endologix Inc: Net Sales, 2018-2020 ($ Million)
Figure 41. Endologix Inc: Revenue Share, by Segment, 2020 (%)
Figure 42. Endologix Inc: Revenue Share, by Region, 2020 (%)
Figure 43. Getinge Group: Net Sales, 2018-2020 ($ Million)
Figure 44. Getinge Group: Revenue Share, by Segment, 2020 (%)
Figure 45. Getinge Group: Revenue Share, by Region, 2020 (%)
Figure 46. Lemaitre Vascular Inc: Net Sales, 2018-2020 ($ Million)
Figure 47. Lemaitre Vascular Inc: Revenue Share, by Segment, 2020 (%)
Figure 48. Lemaitre Vascular Inc: Revenue Share, by Region, 2020 (%)
Figure 49. Medtronic, Inc: Net Sales, 2018-2020 ($ Million)
Figure 50. Medtronic, Inc: Revenue Share, by Segment, 2020 (%)
Figure 51. Medtronic, Inc: Revenue Share, by Region, 2020 (%)
Figure 52. Terumo Medical Corporation: Net Sales, 2018-2020 ($ Million)
Figure 53. Terumo Medical Corporation: Revenue Share, by Segment, 2020 (%)
Figure 54. Terumo Medical Corporation: Revenue Share, by Region, 2020 (%)
Figure 55. W. L. Gore and Associates, Inc: Net Sales, 2018-2020 ($ Million)
Figure 56. W. L. Gore and Associates, Inc: Revenue Share, by Segment, 2020 (%)
Figure 57. W. L. Gore and Associates, Inc: Revenue Share, by Region, 2020 (%)

Executive Summary

According to a new report titled, “Vascular Grafts Market by Product and Medication Class: Global Opportunity Analysis and Industry Forecast, 2021–2030, the vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030.

Vascular grafting is done for the treatment of various vascular complications, such as coronary artery disease (CAD), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and pediatric congenital cardiovascular defects (CCDs). The high blood pressure, cholesterol deposition, cardiac injury, and infections are causative factors for vascular diseases. The diabetes, hypertension, obesity, alcohol consumption, and tobacco smoking are the risk factors for the vascular diseases. The synthetic vascular grafts are made up of expanded polytetrafluoroethylene, Dacron, and polyurethane. However, polyurethane is better able to match the compliance of native vasculature. Hemodialysis access grafts, endovascular aneurysm repair stent grafts, and peripheral vascular grafts are commonly used for vascular grafting procedures.

Factors that drive the growth of the vascular grafts market include rise in number of hospitals, increase geriatric population, and advancement in vascular surgeries. For instance, according to World Population Ageing 2019, a publication by United Nation’s Department of Economic and Social Affairs (DESA), 703 million people are aged 65 years or over globally in 2019. Furthermore, surge of sedentary lifestyle and unhealthy food diet has contributed in the growth of market. Sedentary lifestyle is responsible for deposition of cholesterol in blood vessels.

Moreover, increase in prevalence of hypertension has contributed in the growth of vascular grafts market. Hypertension causes damage to the blood vessels as it adds force to the artery walls and over time, this can damage the blood vessels and lead to more plaque buildup. The narrowed artery limits or blocks the blood flow to the heart muscle. For instance, according to World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years globally had hypertension.

The vascular grafts market is segmented on the basis of product, raw material, end user, and region.

On the basis of product, the vascular grafts market is divided into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. The hemodialysis access graft segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the prevalence of vascular diseases.

On the basis of raw material, the vascular grafts market is divided into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. The polyurethane segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to advantages of polyurethane and better compliance for native vasculature.

On the basis of end users, the market is divided into hospitals and ambulatory surgical centers (ASCs). The hospitals segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to increase in number of hospitals.

On the basis of region, North America accounted for a majority of the global vascular grafts market share in 2020, and is anticipated to remain dominant during the forecast period due to prevalence of vascular diseases. Asia-Pacific is anticipated to witness lucrative growth, owing to the improvement in healthcare facilities, high population, and government initiatives to provide healthcare service.

Impact of COVID-19 Pandemic on Vascular Graft Market (Pre & Post Analysis)

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the vascular grafts market as most hospitals are not operating due to COVID-19 and the ongoing lockdowns in many countries. The COVID-19 virus has serious and life-threatening impact on patients with cardiac patients. However, a huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity to provide improve healthcare services, and this is expected to increase the diagnosis and surgeries of vascular diseases, which contributes in the market growth.

Key Findings Of Study


  • On the basis of products, the hemodialysis access graft segment was the highest contributor to the vascular grafts market in 2020
  • On the basis of raw material, the polyurethane segment dominated the market in 2020
  • On the basis of end users, the hospitals segment dominated the vascular grafts market in 2020
  • On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Companies Mentioned

  • B. Braun Melsungen AG
  • Becton
  • Dickinson And Company
  • ook Medical, Inc.
  • Cordis
  • Endologix Inc.
  • Getinge Group
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information